Growth Metrics

Dexcom (DXCM) Cash & Equivalents Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -69.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.57%
Dec 31, 2025 192.70%
Sep 30, 2025 121.06%
Jun 30, 2025 -35.06%
Mar 31, 2025 6.31%
Dec 31, 2024 -76.30%
Sep 30, 2024 -3.50%
Jun 30, 2024 -21.40%
Mar 31, 2024 36.59%
Dec 31, 2023 -11.83%
Sep 30, 2023 -7.79%
Jun 30, 2023 62.48%
Mar 31, 2023 -12.96%
Dec 31, 2022 -38.98%
Sep 30, 2022 -51.67%
Jun 30, 2022 -36.54%
Mar 31, 2022 -2.43%
Dec 31, 2021 28.74%
Sep 30, 2021 114.45%
Jun 30, 2021 118.64%
Mar 31, 2021 25.52%
Dec 31, 2020 83.24%
Sep 30, 2020 70.25%
Jun 30, 2020 -25.27%
Mar 31, 2020 -54.51%
Dec 31, 2019 -60.76%
Sep 30, 2019 7.68%
Jun 30, 2019 136.24%
Mar 31, 2019 205.69%
Dec 31, 2018 157.53%
Sep 30, 2018 12.35%
Jun 30, 2018 -24.17%
Mar 31, 2018 173.88%
Dec 31, 2017 367.20%
Sep 30, 2017 234.70%
Jun 30, 2017 352.46%
Mar 31, 2017 97.05%
Dec 31, 2016 9.76%
Sep 30, 2016 14.54%
Jun 30, 2016 29.25%
Mar 31, 2016 43.73%
Dec 31, 2015 19.92%
Sep 30, 2015 34.97%
Jun 30, 2015 36.77%
Mar 31, 2015 18.60%
Dec 31, 2014 66.20%
Sep 30, 2014 89.22%
Jun 30, 2014 75.53%
Mar 31, 2014 141.80%
Dec 31, 2013 433.33%
Sep 30, 2013 610.64%
Jun 30, 2013 370.00%
Mar 31, 2013 270.59%
Dec 31, 2012 211.54%
Sep 30, 2012 -73.18%
Jun 30, 2012 -82.30%
Mar 31, 2012 34.03%
Dec 31, 2011 -46.94%
Sep 30, 2011 216.93%
Jun 30, 2011 456.47%